Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian M Sullivan

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Proceedings of the National Academy of Sciences of the United States of America|June 4, 2014
Type I interferon is a therapeutic target for virus-induced lethal vascular damageRoberto Baccala, Megan J Welch, Rosana Gonzalez-Quintial, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2004
Treatment of advanced human immunodeficiency virus type 1 disease with the viral entry inhibitor PRO 542Jeffrey M Jacobson, Robert J Israel, Israel Lowy, et al.
Advanced Healthcare Materials|February 24, 2026
Peptide Substitutes of PEG: Biological Outcomes on Prospective Lipid Nanoparticle Shielding MaterialsRajesh Mukthavaram, Steven P Tanis, Amit Sagi, et al.
NPJ Vaccines|November 28, 2022
Immune gene expression analysis indicates the potential of a self-amplifying Covid-19 mRNA vaccineEugenia Z Ong, Jia Xin Yee, Justin S G Ooi, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2018
Analysis of CD8<sup>+</sup> T cell response during the 2013-2016 Ebola epidemic in West AfricaSaori Sakabe, Brian M Sullivan, Jessica N Hartnett, et al.
The Journal of Infectious Diseases|May 22, 2020
Ebola-Specific CD8+ and CD4+ T-Cell Responses in Sierra Leonean Ebola Virus Survivors With or Without Post-Ebola SequelaeStephanie M LaVergne, Saori Sakabe, Lansana Kanneh, et al.
Journal of Virology|April 10, 2020
Identification of Common CD8<sup>+</sup> T Cell Epitopes from Lassa Fever Survivors in Nigeria and Sierra LeoneSaori Sakabe, Jessica N Hartnett, Nhi Ngo, et al.
Plos Pathogens|March 7, 2020
High crossreactivity of human T cell responses between Lassa virus lineagesBrian M Sullivan, Saori Sakabe, Jessica N Hartnett, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 6, 2021
A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in miceRuklanthi de Alwis, Esther S Gan, Shiwei Chen, et al.
The Journal of Infectious Diseases|July 13, 2016
An Outbreak of Ebola Virus Disease in the Lassa Fever ZoneAugustine Goba, S Humarr Khan, Mbalu Fonnie, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Proceedings of the National Academy of Sciences of the United States of America|June 4, 2014
Type I interferon is a therapeutic target for virus-induced lethal vascular damageRoberto Baccala, Megan J Welch, Rosana Gonzalez-Quintial, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2004
Treatment of advanced human immunodeficiency virus type 1 disease with the viral entry inhibitor PRO 542Jeffrey M Jacobson, Robert J Israel, Israel Lowy, et al.
Advanced Healthcare Materials|February 24, 2026
Peptide Substitutes of PEG: Biological Outcomes on Prospective Lipid Nanoparticle Shielding MaterialsRajesh Mukthavaram, Steven P Tanis, Amit Sagi, et al.
NPJ Vaccines|November 28, 2022
Immune gene expression analysis indicates the potential of a self-amplifying Covid-19 mRNA vaccineEugenia Z Ong, Jia Xin Yee, Justin S G Ooi, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2018
Analysis of CD8<sup>+</sup> T cell response during the 2013-2016 Ebola epidemic in West AfricaSaori Sakabe, Brian M Sullivan, Jessica N Hartnett, et al.
The Journal of Infectious Diseases|May 22, 2020
Ebola-Specific CD8+ and CD4+ T-Cell Responses in Sierra Leonean Ebola Virus Survivors With or Without Post-Ebola SequelaeStephanie M LaVergne, Saori Sakabe, Lansana Kanneh, et al.
Journal of Virology|April 10, 2020
Identification of Common CD8<sup>+</sup> T Cell Epitopes from Lassa Fever Survivors in Nigeria and Sierra LeoneSaori Sakabe, Jessica N Hartnett, Nhi Ngo, et al.
Plos Pathogens|March 7, 2020
High crossreactivity of human T cell responses between Lassa virus lineagesBrian M Sullivan, Saori Sakabe, Jessica N Hartnett, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 6, 2021
A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in miceRuklanthi de Alwis, Esther S Gan, Shiwei Chen, et al.
The Journal of Infectious Diseases|July 13, 2016
An Outbreak of Ebola Virus Disease in the Lassa Fever ZoneAugustine Goba, S Humarr Khan, Mbalu Fonnie, et al.
Pageof 3